Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralesional vitamin D versus triamcinolone acetonide for keloids
IRCT20120215009014N609Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- May 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in keloid comparing Intralesional vitamin D with Intralesional triamcinolone acetonide (2 arms). Primary endpoints: Scar severity and Pain intensity. Started May 2026; status: completed.
02
Drugs
vitamin dtriamcinolone acetonide
03
Conditions
keloid
Beyond the preview
Go deeper on IRCT20120215009014N609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N609.